Royal DSM N.V. opened the DSM China regional headquarters and R&D campus in January of 2009. The 26,000-sm facility is located in the Zhangjiang Hi-Tech Park in Shanghai and has attained LEED Gold sustainable design certification. Royal DSM N.V., a life and materials sciences company based in the Heerlen, Netherlands, will house 600 employees in the new facility.
Johns Hopkins University School of Medicine will relocate the Brain Sciences Institute to 25,000 sf of laboratory space in the John G. Rangos Sr. Building in Baltimore. Located in the Science + Technology Park at Johns Hopkins, the project was developed by Forest City-New East Baltimore Partnership. The facility will be the center of the Institute's operations as well as housing labs and offices for the NeuroTranslational Program.
Torrey Pines Institute for Molecular Studies opened its $40 million headquarters and biomedical research facility in Port St. Lucie, Fla., in January of 2009. Located in the Florida Center for Innovation at Tradition, the 103,000-sf facility was built by Suffolk Construction Co. Ground was broken for the project in March of 2007. Construction began in February of 2008 and reached completion in September of 2008, three months ahead of schedule.
California-based Mann Research Center is planning to construct a $100 million life sciences complex in Port St. Lucie, Fla. The 400,000-sf research facility will be located in the Florida Center for Innovation at Tradition.
Scripps Research Institute will celebrate the opening of the three-building Scripps Florida campus in Jupiter on February 26, 2009. The 350,000-sf project is sited on 40 acres adjoining Florida Atlantic University and houses biomedical research laboratories, technology space, and offices.
Pahang Bioscience is partnering with BCRO Stem Cell Transplantation to create a RM300 million stem cell research center in Temerloh, Malaysia. The facility will include an animal research laboratory, stem cell culture facilities, medical treatment areas, and a closed-colony rabbit farm.
Hamilton Health Sciences is planning to construct the $90 million David Braley Cardiac, Vascular and Stroke Research Institute. Located on the campus of Hamilton General Hospital in Hamilton, ON, the six-story, 165,000-sf facility will house the Population Health Research Institute and the Fraser Mustard Thrombosis Research Institute. Designed to foster interaction and collaboration, the project will include laboratories, offices, meeting rooms, and breakout spaces. Construction will begin in 2010.
The University of Michigan will purchase Pfizer’s 174-acre campus in Ann Arbor. Housing 1.97 million gsf in 30 buildings, the site will provide 1.3 million sf of research space and 420,000 sf of office space. The $108 million acquisition will enable the University of Michigan to expand its research operations in biomedical science. Occupancy will begin in late 2009.
The Wistar Institute opened a $1.1 million molecular screening facility on its Philadelphia campus in December of 2008. The facility was created in partnership with the University of the Sciences as the centerpiece of the Center for Chemical Biology and Translational Medicine. Using advanced screening technologies, scientists will be able to identify and characterize new molecules and compounds to create therapeutic drugs.
The University of Nevada School of Medicine is constructing the Center for Molecular Medicine in Reno. Designed by Dekker/Perich/Sabatini, the 100,000-sf project broke ground in March 2007 and is expected to reach completion in 2009. The facility will accommodate basic science research in microbiology, pharmacology, and physiology. The project will include a vivarium, research laboratories, offices, two meeting rooms, and an auditorium.
Ortec Inc. completed a $7.2 million expansion of its manufacturing cleanroom facilities in Piedmont, S.C., in December of 2008. The project added 2,600 sf of Class 100,000 cleanroom space for the custom manufacturing of biomaterials and polymers for the medical device and pharmaceutical industries. The expansion also features USP water and cold storage facilities.
Medicago is initiating a $1.5 million expansion of its Quebec City manufacturing facility to support avian flu vaccine production for clinical trials. The 2,500-sf addition will include purification, storage, and cGMP vaccine manufacturing space. Construction will begin in January 2009 and reach completion by year-end 2009. Medicago’s existing building, housing 10,000-sf of BSL-2 space and 3,000-sf of cGMP manufacturing space, will begin production of an H5N1 vaccine for Phase 1 clinical trials in 2009. The new addition will house Phase 2 clinical studies.
The University of Oklahoma Cancer Institute is slated for completion in summer of 2009. The $210 million, 220,000-sf National Cancer Institute is located at Oklahoma Health Center in Oklahoma City. Construction began on the seven-story project in early 2008.
Victoria Hospital began construction in fall of 2008 on a $4 million cancer research center in London, Ontario. Sited on the third floor of the Victoria Research Laboratories adjacent to Victoria Hospital’s cancer center, the 8,300-sf Gerald C. Baines Centre for Translational Research will house clinical research facilities, interdisciplinary research space, and an imaging laboratory. Completion is expected by early 2010.
The University of Edinburgh broke ground on a £58 million biomedical research center in December of 2008. Located on the University’s Easter Bush campus in Roslin, U.K., the project will house laboratories and offices for research in genetics, developmental biology, neuroscience, immunology, infectious diseases, and animal sciences. The facility is slated for completion in 2011 and will be complemented by a new veterinary teaching building and small animal hospital. The project architect is CUH2A.
